Location History:
- Marcy l'Etoile, FR (2016)
- Paris, FR (2024)
Company Filing History:
Years Active: 2016-2024
Title: The Innovative Contributions of Laurence Quemeneur
Introduction
Laurence Quemeneur is a notable inventor based in Marcy l'Etoile, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines and therapeutic compositions. With a total of 2 patents, Quemeneur's work has the potential to impact public health positively.
Latest Patents
One of Quemeneur's latest patents is for a Meningococcal B recombinant vaccine. This immunogenic composition includes a combination of meningococcal antigens, which comprises at least one factor H binding protein (fHBP) A protein, at least one fHBP B protein, at least one adhesin A (NadA) protein, and at least one detergent-extracted Outer Membrane Vesicle (dOMV). The combination of these antigens provides broad coverage against various bacterial strains, and the patent also discusses methods for eliciting an immune response using this composition. Another significant patent involves Porphyromonas gingivalis polypeptides, which are aimed at eliciting an immune response against infections such as periodontitis. This patent outlines compositions and methods that include polypeptides, fragments, and variants, along with corresponding polynucleotides useful in diagnosis, prevention, and therapy.
Career Highlights
Quemeneur is currently associated with Sanofi Pasteur Inc., a leading company in the field of vaccines and immunology. His work at Sanofi Pasteur has allowed him to focus on innovative solutions to combat infectious diseases.
Collaborations
Quemeneur has collaborated with several professionals in his field, including Jacqueline McCluskey and Nadège Arnaud-Barbe. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Laurence Quemeneur's innovative work in vaccine development and immunology showcases his commitment to improving public health through scientific research. His patents reflect significant advancements in the field, and his collaborations further enhance the impact of his contributions.